Evidence map›Paper›PMID 40079430›Full record

ArticlePsychiatry and clinical neurosciences2025

Neuropsychiatric symptoms cluster and fluctuate over time in behavioral variant frontotemporal dementia.

Christopher B Morrow, Vidyulata Kamath, Bradford C Dickerson, Mark Eldaief, Neguine Rezaii, Bonnie Wong, Scott McGinnis, Ryan Darby, Adam M Staffaroni, Maria I Lapid and 16 more

Abstract read
In one paragraph

Article in Psychiatry and clinical neurosciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Depression and apathy in frontotemporal dementia: a short assessment of facts and outlook.Journal of neural transmission (Vienna, Austria : 1996) · 2026
    Review
  2. Article
  3. Article
  4. Uncovering the Role of Neuropsychiatric Symptoms in Cognitive Impairment Progression.Proceedings. IEEE International Conference on Bioinformatics and Biomedicine · 2025
    Article
  5. Review
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors.

Christopher B MorrowDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID https://orcid.org/0000-0003-4600-1802
Vidyulata KamathDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Bradford C DickersonDepartment of Neurology, Massachusetts General Hospital/Harvard Medical School, Charlestown, Massachusetts, USA.
Mark EldaiefDepartment of Neurology, Massachusetts General Hospital/Harvard Medical School, Charlestown, Massachusetts, USA.
Neguine RezaiiDepartment of Neurology, Massachusetts General Hospital/Harvard Medical School, Charlestown, Massachusetts, USA.
Bonnie WongDepartment of Neurology, Massachusetts General Hospital/Harvard Medical School, Charlestown, Massachusetts, USA.
Scott McGinnisDepartment of Neurology, Massachusetts General Hospital/Harvard Medical School, Charlestown, Massachusetts, USA.
Ryan DarbyDepartment of Neurology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Adam M StaffaroniDepartment of Neurology, Memory and Aging Center, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California, USA.
Maria I LapidDepartment of Psychiatry and Neurology, Mayo Clinic, Rochester, Minnesota, USA.
Belen PascualDepartment of Neurology, Houston Methodist Research Institute, Houston, Texas, USA.
Julio C RojasDepartment of Neurology, Memory and Aging Center, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California, USA.
Joseph C MasdeuDepartment of Neurology, Houston Methodist Research Institute, Houston, Texas, USA.
Kyrana TsapkiniDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Edward D HueyDepartment of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, Rhode Island, USA.
Daniel W FisherDepartment of Neurology, University of Washington School of Medicine, Seattle, Washington, USA.
Alexander PantelyatDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Akshata BalajiDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Eric SahDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID https://orcid.org/0000-0001-7522-2036
Irene LitvanDepartment of Neurosciences, University of California, San Diego, La Jolla, California, USA.
Katya RascovskyDepartment of Neurology and Penn Frontotemporal Degeneration Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Nupur GhoshalDepartment of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.
Kimiko Domoto-ReillyDepartment of Neurology, University of Washington School of Medicine, Seattle, Washington, USA.
John KornakDepartment of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA.
Chiadi U OnyikeDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
ALLFTD Consortium

Funding

Technology and Remote Assessment CoreU19AG063911 · NIA · MAYO CLINIC ROCHESTER · PI WILLIAM W SEELEY · 2019 to 2026
$120.9M
UCSD Shiley-Marcos Alzheimer's Disease Research Center P30P30AG062429 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Subhojit Roy · 2019 to 2026
$34.9M
Research Education ComponentP30AG066507 · NIA · JOHNS HOPKINS UNIVERSITY · PI Corinne Pettigrew · 2020 to 2026
$29.3M
University of Washington Alzheimer's Disease Research CenterP30AG066509 · NIA · UNIVERSITY OF WASHINGTON · PI Amanda D. Boyd · 2020 to 2026
$29.0M
Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects (LEFFTDS)U01AG045390 · NIA · MAYO CLINIC ROCHESTER · PI BOEVE, BRADLEY F, ROSEN, HOWARD J · 2014 to 2018
$16.9M
Institutional Career Development CoreKL2TR003099 · NCATS · JOHNS HOPKINS UNIVERSITY · PI GEBO, KELLY A · 2019 to 2023
$7.9M
Neurobehavior, Neuropathology, and Risk Factors in Alzheimer's DiseaseT32AG052354 · NIA · UNIVERSITY OF WASHINGTON · PI Brian C. Kraemer, ELAINE R. PESKIND · 2016 to 2026
$6.7M
Phase II clinical trial of transcranial direct current stimulation in the treatment of primary progressive aphasiaR01AG075111 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Roy H Hamilton, Kyrana Tsapkini · 2022 to 2026
$6.7M
Training - The Frontotemporal Lobar Degeneration Clinical Research ConsortiumU54NS092089 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BOXER, ADAM L. · 2014 to 2018
$6.4M
BIOMARKER DISCOVERY AND VALIDATION IN PSPU01NS102035 · NINDS · JOHNS HOPKINS UNIVERSITY · PI PANTELYAT, ALEXANDER Y. · 2018 to 2022
$4.5M
Targeting language-specific and executive-control networks with transcranial direct current stimulation in aphasic ADR01AG075404 · NIA · JOHNS HOPKINS UNIVERSITY · PI Kyrana Tsapkini · 2022 to 2026
$4.0M
Advanced MR Imaging of Olfactory Impairment in Prodromal Alzheimer's DiseaseR01AG064093 · NIA · HUGO W. MOSER RES INST KENNEDY KRIEGER · PI BAKKER, ARNOLD, HUA, JUN · 2020 to 2024
$3.9M
Alzheimer's AssociationAssociation for Frontotemporal DegenerationNCATS NIH HHS KL2 TR003099NCATS NIH HHS KL2TR003099NIA NIH HHS K23 AG059888NIA NIH HHS K23 AG059891NIA NIH HHS K23 AG088248NIA NIH HHS K23AG088248NIA NIH HHS L30 AG083912NIA NIH HHS P30 AG062429NIA NIH HHS P30 AG066507NIA NIH HHS P30 AG066509NIA NIH HHS R01 AG064093NIA NIH HHS R01 AG068881NIA NIH HHS R01 AG075111NIA NIH HHS R01 AG075404NIA NIH HHS R44 AG080861NIA NIH HHS T32 AG052354NIA NIH HHS U01 AG045390NIA NIH HHS U19 AG063911NIA NIH HHS UW CSTPA T32AG052354NIH HHS U01AG045390-01A1NIH HHS U19AG063911NIH HHS U54NS092089-01NINDS NIH HHS R01 NS108452NINDS NIH HHS U01 NS102035NINDS NIH HHS U54 NS092089Robert and Nancy Hall Brain Research FundTau Consortium
6 · The paper itself

Abstract

aimCognitive and behavioral phenomena define behavioral variant frontotemporal dementia (bvFTD), but neuropsychiatric symptoms (NPS) outside the core criteria are common throughout the illness. Identifying how NPS cluster in bvFTD may guide development of future therapies.

methodsParticipants (n = 354) with sporadic and genetic bvFTD were enrolled in the ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration Consortium. Dementia stage was defined as early (CDR® plus NACC FTLD ≤1) or advanced (CDR® plus NACC FTLD ≥1). Baseline and annual follow-up visit data were analyzed to compare NPS across stages of bvFTD. Psychiatric states were captured using the Neuropsychiatric Inventory-Questionnaire and Clinician Judgment of Symptoms. Polychoric cluster analysis was used to describe NPS clusters.

resultsNPS were highly prevalent (≥90%) in early and late bvFTD. Four NPS clusters were identified based on magnitude of factor loadings: affective, disinhibited, compulsive, and psychosis. Neuropsychiatric symptoms fluctuated across visits. In the affective cluster, depression showed the least visit-to-visit stability. In the disinhibited cluster, elation showed the least stability. Symptoms in the psychosis and compulsive clusters (hallucinations, delusions, obsessions/compulsions, and hyperorality) were largely stable, persisting from visit-to-visit in more than 50% of cases. Symptoms in the affective and disinhibited cluster were associated with the highest caregiver burden, while symptoms in the obsessive cluster were associated with the most functional impairment.

conclusionNPS in bvFTD are frequent and cluster into four discrete groups. The fluctuating nature of some NPS in bvFTD suggests that they may not be reliable markers of disease progression or stage.

Indexed as

Frontotemporal DementiaPsychotic DisordersAgedCluster AnalysisDisease ProgressionFemaleHumansLongitudinal StudiesMaleMiddle Agedbehavioral symptomsbehavioral variant frontotemporal dementiafrontotemporal lobar degenerationFTLDneuropsychiatry

Identifiers

PMID40079430
PMCPMC12133425

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.